{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:02:06Z","timestamp":1778814126252,"version":"3.51.4"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00511","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T13:35:35Z","timestamp":1587735335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole"],"prefix":"10.3389","volume":"11","author":[{"given":"Nadeeka S.","family":"Udawatte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiruma V.","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaminda J.","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1091581818819791","article-title":"Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies","volume":"38","author":"Adedeji","year":"2019","journal-title":"Int. J. Toxicol."},{"key":"B2","first-page":"5276","article-title":"Chemosensitivity Testing of Human Tumors Using a Microplate Adenosine Triphosphate Luminescence Assay: Clinical Correlation for Cisplatin Resistance of Ovarian Carcinoma","volume":"55","author":"Andreotti","year":"1995","journal-title":"Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/01926230490465874","article-title":"Relationships Between Organ Weight and Body\/Brain Weight in the Rat: WhaT Is the Best Analytical Endpoint","volume":"32","author":"Bailey","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"B4","unstructured":"2019"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/cpt.1093","article-title":"Evaluating the Use of KIM-1 in Drug Development and Research Following FDA Qualification","volume":"104","author":"Chen","year":"2018","journal-title":"Clin. Pharmacol. Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/biom5010142","article-title":"Oxidative stress responses in the human fungal pathogen, Candida albicans","volume":"5","author":"Dantas Ada","year":"2015","journal-title":"Biomolecules"},{"key":"B7","doi-asserted-by":"publisher","first-page":"F313","DOI":"10.1152\/ajprenal.00180.2006","article-title":"Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase","author":"de Borst","year":"2006","journal-title":"Am. J. Physiol-Renal Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nbt.1625","article-title":"Renal biomarker qualification submission: A dialog between the FDA-EMEA and Predictive Safety Testing Consortium","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tox.2007.12.024","article-title":"Biomarkers of nephrotoxic acute kidney injury","volume":"245","author":"Ferguson","year":"2008","journal-title":"Toxicology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1208\/s12248-011-9301-x","article-title":"Biomarkers for Drug-Induced Renal Damage and Nephrotoxicity\u2014An Overview for Applied Toxicology","volume":"13","author":"Fuchs","year":"2011","journal-title":"AAPS J."},{"key":"B12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-012330215-1\/50016-8","author":"Gad","year":"2002","journal-title":"Handbook of Toxicologic Pathology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jnr.10825","article-title":"Glutamate Uptake Inhibitor L-Trans-Pyrrolidine 2,4-Dicarboxylate Becomes Neurotoxic in the Presence of Subthreshold Concentrations of Mitochondrial Toxin 3-Nitropropionate: Involvement of Mitochondrial Reducing Activity and ATP Production","volume":"74","author":"Garc\u00eda","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"B14","first-page":"0","article-title":"In Vitro Study of Potential Nephrotoxicity Biomarkers through Gene Expression Using Reverse sequence","volume":"1","author":"Grossi","year":"2017","journal-title":"J. Toxicol. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1139\/y11-078","article-title":"Corrigendum: Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity","volume":"89","author":"Gunness","year":"2011","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ki.2011.120","volume":"80","author":"Havasi","year":"2011","journal-title":"Kidney Int."},{"key":"B17","volume-title":"Drug discovery and development : technology in transition.","author":"Hill","year":"2012"},{"key":"B18","doi-asserted-by":"publisher","first-page":"F552","DOI":"10.1152\/ajprenal.00285.2002","article-title":"Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury","volume":"286","author":"Ichimura","year":"2004","journal-title":"Am. J. Physiol.-Renal Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1172\/JCI34487","article-title":"Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells","volume":"118","author":"Ichimura","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B20","first-page":"3","article-title":"Chapter 5.4: Vascular acces for renal replacement therapy","volume-title":"AKI\u2019, KDIGO Clinical Practice Guideline for Acute Kidney Injury","year":"2012"},{"key":"B21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00424-012-1163-2","article-title":"\u2018The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule","volume":"464","author":"Jenkinson","year":"2012","journal-title":"Pfl\u00fcgers Archiv : Eur. J. Physiol."},{"key":"B22","first-page":"481","article-title":"of Kidney Diseases and Transplantation Review Article Amphotericin B Nephrotoxicity","volume":"13","author":"Journal","year":"2002","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"B23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/14787210.2018.1528872","article-title":"Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis","volume":"16","author":"Keane","year":"2018","journal-title":"Expert Rev. Anti-Infective Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates","volume":"3","author":"Kola","year":"2004","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/155989771313005","article-title":"In Search of the Holy Grail of Anticoagulant Therapy","volume":"13","author":"Kuznar","year":"2015","journal-title":"MD Conf. Express"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1681\/ASN.2014030262","article-title":"Regulated Cell Death in AKI","volume":"25","author":"Linkermann","year":"2014","journal-title":"J.  Am. Soc. Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/1087057104265386","article-title":"Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines","volume":"9","author":"Mueller","year":"2004","journal-title":"J. Biomol. Screening"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.13040\/IJPSR.0975-8232.5(4).1525-32","article-title":"What Suits Best for Organ Weight Analysis : Review of Relationship Between Organ Weight and Body \/ Brain Weight for Rodent Toxicity Studies","volume":"5","author":"Nirogi","year":"2014","journal-title":"Int. J. Pharmaceutical Sci. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1128\/AAC.00870-07","article-title":"Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products","volume":"52","author":"Olson","year":"2008","journal-title":"Antimicrobial Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: Selected new molecules and beyond","volume":"9","author":"Ostrosky-Zeichner","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jbiotec.2010.09.488","article-title":"Determination of yeast cell viability: Viable count vs ATP-based bioluminescence assay","volume":"150","author":"Paciello","year":"2010","journal-title":"J. Biotechnol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/CCM.0b013e318168c652","article-title":"New biomarkers of acute kidney injury","volume":"36","author":"Parikh","year":"2008","journal-title":"Crit. Care Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/13693780701218689","article-title":"Nosocomial fungal infections: Epidemiology, diagnosis, and treatment","volume":"45","author":"Perlroth","year":"2007","journal-title":"Med. Mycol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am. J. Med."},{"key":"B36","year":"2019"},{"key":"B37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1293\/tox.26.29","article-title":"Change trends of organ weight background data in Sprague Dawley rats at different ages","author":"Piao","year":"2013","journal-title":"J. Toxicol. Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pharmthera.2013.01.002","article-title":"CellTiter Glo PROMEGA","volume":"138","year":"2013","journal-title":"Data Sheet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.ki.5002467.Kidney","article-title":"Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxici","volume":"72","author":"Prozialeck","year":"2009","journal-title":"Kidney Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/toxsci\/kfn040","article-title":"Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro","volume":"103","author":"Rached","year":"2008","journal-title":"Toxicol. Sci."},{"key":"B41","article-title":"Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-2013","author":"Riss","year":"2004"},{"key":"B42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ki.1994.6","article-title":"HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney","volume":"45","author":"Ryan","year":"1994","journal-title":"Kidney Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/toxsci\/kfp070","article-title":"Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity","volume":"109","author":"Sieber","year":"2009","journal-title":"Toxicol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/sj.clpt.6100243","article-title":"Preclinical predictors of clinical safety: Opportunities for improvement","volume":"82","author":"Sistare","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nbt.1634","article-title":"Towards consensus practices to qualify safety biomarkers for use in early drug development","volume":"28","author":"Sistare","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.gene.2015.08.009","article-title":"Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over\/underestimation of cell viability","volume":"574","author":"Stepanenko","year":"2015","journal-title":"Gene. Elsevier B.V."},{"key":"B47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tox.2010.04.015","article-title":"Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats","volume":"273","author":"Tonomura","year":"2010","journal-title":"Toxicology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2018.00164","article-title":"Use of Haploid Model of Candida albicans to Uncover Mechanism of Action of a Novel Antifungal Agent","volume":"8","author":"Truong","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nbt.1623.Kidney","article-title":"KIM1 iutperforms traditional biomarkers of kidney infury","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/jac\/32.5.723","article-title":"Efficacies of amphotericin b-desoxycholate (fungizone), liposomal amphotericin b (ambisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice","volume":"32","author":"Van Etten","year":"1993","journal-title":"J. Antimicrobial Chemother."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096801","article-title":"IHC profiler: An open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples","volume":"9","author":"Varghese","year":"2014","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1128\/AAC.45.3.679-685.2001","article-title":"Apoptosis Contributes to Amphotericin B- Induced Nephrotoxicity","volume":"45","author":"Varlam","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1177\/0192623312444765","article-title":"Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats","volume":"40","author":"Vinken","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/0192623313492044","article-title":"Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury","volume":"42","author":"Wadey","year":"2014","journal-title":"Toxicol. Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida Species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085836","article-title":"In vitro and in vivo activity of a novel antifungal small molecule against Candida infections","volume":"9","author":"Wong","year":"2014","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1172\/JCI75417","article-title":"KIM-1 \u2013 mediated phagocytosis reduces acute injury to the kidney Find the latest version : KIM-1 \u2013 mediated phagocytosis reduces acute injury to the kidney","volume":"125","author":"Yang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/toxsci\/kfm260","article-title":"Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium","volume":"101","author":"Zhou","year":"2008","journal-title":"Toxicol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T13:35:39Z","timestamp":1587735339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":60,"alternative-id":["10.3389\/fphar.2020.00511"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00511","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"article-number":"511"}}